-
1
-
-
0015642617
-
Phase II evaluation of Adriamycin in human neoplasia
-
O'Bryan RM, Luce JK, Talley RW, et al: Phase II evaluation of Adriamycin in human neoplasia. Cancer 1973;32:1-8.
-
(1973)
Cancer
, vol.32
, pp. 1-8
-
-
O'Bryan, R.M.1
Luce, J.K.2
Talley, R.W.3
-
2
-
-
0026604140
-
Chemotherapy in the multidisciplinary approach to soft tissue sarcomas
-
Verweij J, van Oosterom AT, Somers R, et al: Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. Ann Oncol 1992;3:S75-S80.
-
(1992)
Ann Oncol
, vol.3
-
-
Verweij, J.1
Van Oosterom, A.T.2
Somers, R.3
-
3
-
-
0017704418
-
Dose-response evaluation of Adriamycin in human neoplasia
-
O'Bryan RM, Baker LH, Gottlieb JE, et al: Dose-response evaluation of Adriamycin in human neoplasia. Cancer 1977;39:1940-1948.
-
(1977)
Cancer
, vol.39
, pp. 1940-1948
-
-
O'Bryan, R.M.1
Baker, L.H.2
Gottlieb, J.E.3
-
4
-
-
0020520549
-
Carminomycin versus Adriamycin in advanced soft tissue sarcoma. An EORTC randomised Phase II study
-
Bramwell VHC, Mouridsen HT, Mulder JH, et al: Carminomycin versus Adriamycin in advanced soft tissue sarcoma. An EORTC randomised Phase II study. Eur J Cancer 1983;19: 1097-1104.
-
(1983)
Eur J Cancer
, vol.19
, pp. 1097-1104
-
-
Bramwell, V.H.C.1
Mouridsen, H.T.2
Mulder, J.H.3
-
5
-
-
0020354811
-
A comparison of Adriamycin versus vincristine and Adriamycin and cyclophosphamide for advanced sarcoma
-
Schoenfeld D, Rosenbaum C, Horton J, et al: A comparison of Adriamycin versus vincristine and Adriamycin and cyclophosphamide for advanced sarcoma. Cancer 1982;50:2757-2762.
-
(1982)
Cancer
, vol.50
, pp. 2757-2762
-
-
Schoenfeld, D.1
Rosenbaum, C.2
Horton, J.3
-
6
-
-
0021173596
-
Cyvadic in advanced soft tissue sarcoma -a randomised study comparing two schedules
-
Pinedo HM, Bramwell VHC, Mouridsen VHC, et al: Cyvadic in advanced soft tissue sarcoma -a randomised study comparing two schedules. Cancer 1984;53:1825-1832.
-
(1984)
Cancer
, vol.53
, pp. 1825-1832
-
-
Pinedo, H.M.1
Bramwell, V.H.C.2
Mouridsen, V.H.C.3
-
7
-
-
0019503168
-
Protected environment-prophylactic antibiotic program for malignant sarcoma: Randomised trial during remission induction chemotherapy
-
Bodey GP, Rodriguez V, Murphy WK, Burgess A, Benjamin RS: Protected environment-prophylactic antibiotic program for malignant sarcoma: Randomised trial during remission induction chemotherapy. Cancer 1981;47:2422-2429.
-
(1981)
Cancer
, vol.47
, pp. 2422-2429
-
-
Bodey, G.P.1
Rodriguez, V.2
Murphy, W.K.3
Burgess, A.4
Benjamin, R.S.5
-
8
-
-
0023428586
-
Adriamycin versus epirubicin in advanced soft tissue sarcomas: A randomised phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group
-
Mouridsen HT, Bastholt L, Somers R, et al: Adriamycin versus epirubicin in advanced soft tissue sarcomas: A randomised phase II/phase III study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol 1987;23:1477-1483.
-
(1987)
Eur J Cancer Clin Oncol
, vol.23
, pp. 1477-1483
-
-
Mouridsen, H.T.1
Bastholt, L.2
Somers, R.3
-
9
-
-
0001511895
-
A phase III study comparing Adriamycin versus two schedules of high dose epirubicin in advanced soft tissue sarcoma
-
Dombernowsky P, Mouridsen H, Nielsen OS, et al: A phase III study comparing Adriamycin versus two schedules of high dose epirubicin in advanced soft tissue sarcoma. Proc Am Soc Clin Oncol 1995;14:515.
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 515
-
-
Dombernowsky, P.1
Mouridsen, H.2
Nielsen, O.S.3
-
10
-
-
0002427045
-
Sarcomas of soft tissues
-
DeVita VT Jr, Hellman S, Rosenberg SA (eds): Philadelphia, Lippincott
-
Yang JC, Rosenberg SA, Glatstein EJ, Antman KH: Sarcomas of soft tissues; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology, ed 4. Philadelphia, Lippincott, 1995.
-
(1995)
Cancer Principles and Practice of Oncology, Ed 4
-
-
Yang, J.C.1
Rosenberg, S.A.2
Glatstein, E.J.3
Antman, K.H.4
-
11
-
-
0016854617
-
Erfahrungen mit der fraktionierten Ifosfamid-Stosstherapie bei generalisierten malignen Tumoren
-
Hoefer-Janker H, Scheef W, Gunther U, Huls W: Erfahrungen mit der fraktionierten Ifosfamid-Stosstherapie bei generalisierten malignen Tumoren. Med Welt 1975;26:972-979.
-
(1975)
Med Welt
, vol.26
, pp. 972-979
-
-
Hoefer-Janker, H.1
Scheef, W.2
Gunther, U.3
Huls, W.4
-
12
-
-
0020579134
-
High dose alkylating therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft tissue sarcoma
-
Stuart-Harris RC, Harper PG, Parsons CA, et al: High dose alkylating therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft tissue sarcoma. Cancer Chemother Pharmacol 1983;11:69-72.
-
(1983)
Cancer Chemother Pharmacol
, vol.11
, pp. 69-72
-
-
Stuart-Harris, R.C.1
Harper, P.G.2
Parsons, C.A.3
-
13
-
-
0023142209
-
Cyclophosphamide versus ifosfamide: Final report of a randomised phase II trial in adult soft tissue sarcoma
-
Bramwell VHC, Mouridsen HT, Santoro A, et al: Cyclophosphamide versus ifosfamide: Final report of a randomised phase II trial in adult soft tissue sarcoma. Eur J Cancer 1987;23:311-321.
-
(1987)
Eur J Cancer
, vol.23
, pp. 311-321
-
-
Bramwell, V.H.C.1
Mouridsen, H.T.2
Santoro, A.3
-
15
-
-
0023394794
-
Fludarabine phosphate: Phase II evaluation in advanced soft tissue sarcomas
-
Pazdur R, Samson MK, Baker L: Fludarabine phosphate: Phase II evaluation in advanced soft tissue sarcomas. Am J Clin Oncol 1987;10: 341-343.
-
(1987)
Am J Clin Oncol
, vol.10
, pp. 341-343
-
-
Pazdur, R.1
Samson, M.K.2
Baker, L.3
-
16
-
-
0021238251
-
Phase II evaluation of PALA in patients with refractory metastatic sarcomas
-
Kurzrock R, Yap BS, Plager C, et al: Phase II evaluation of PALA in patients with refractory metastatic sarcomas. Am J Clin Oncol 1984;7: 305-307.
-
(1984)
Am J Clin Oncol
, vol.7
, pp. 305-307
-
-
Kurzrock, R.1
Yap, B.S.2
Plager, C.3
-
17
-
-
0025760887
-
A phase II trial of PALA plus dipyridamole in patients with advanced soft tissue sarcoma
-
Casper ES, Baselga J, Smart TB, Magill GB, Markman M, Ranhosky A: A phase II trial of PALA plus dipyridamole in patients with advanced soft tissue sarcoma. Cancer Chemother Pharmacol 1991;28:51-54.
-
(1991)
Cancer Chemother Pharmacol
, vol.28
, pp. 51-54
-
-
Casper, E.S.1
Baselga, J.2
Smart, T.B.3
Magill, G.B.4
Markman, M.5
Ranhosky, A.6
-
18
-
-
0025739009
-
A phase II trial of trimetrexate in patients with advanced soft tissue sarcoma
-
Licht JD, Gonin R, Antman K: A phase II trial of trimetrexate in patients with advanced soft tissue sarcoma. Cancer Chemother Pharmacol 1991;28:223-225.
-
(1991)
Cancer Chemother Pharmacol
, vol.28
, pp. 223-225
-
-
Licht, J.D.1
Gonin, R.2
Antman, K.3
-
19
-
-
0025998839
-
Phase II trials of trimetrexate in advanced adult soft tissue sarcomas. Studies of the Canadian Sarcoma Group and National Cancer Institute of Canada Clinical Trials Group
-
Eisenhauer EA, Wierzbicki R, Knowling M, Bramwell VHC, Quirt IC: Phase II trials of trimetrexate in advanced adult soft tissue sarcomas. Studies of the Canadian Sarcoma Group and National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 1991;2:689-690.
-
(1991)
Ann Oncol
, vol.2
, pp. 689-690
-
-
Eisenhauer, E.A.1
Wierzbicki, R.2
Knowling, M.3
Bramwell, V.H.C.4
Quirt, I.C.5
-
20
-
-
0027279546
-
Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma
-
Casper ES, Christman KL, Schwartz GK, Johnson B, Bretman MF, Bertino JR: Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma. Cancer 1993;72:766-770.
-
(1993)
Cancer
, vol.72
, pp. 766-770
-
-
Casper, E.S.1
Christman, K.L.2
Schwartz, G.K.3
Johnson, B.4
Bretman, M.F.5
Bertino, J.R.6
-
21
-
-
0025150176
-
Randomised comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft tissue sarcomas
-
Borden EC, Amato DA, Edmonson JH, Ritch PS, Shiraki M: Randomised comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft tissue sarcomas. Cancer 1990;66:862-867.
-
(1990)
Cancer
, vol.66
, pp. 862-867
-
-
Borden, E.C.1
Amato, D.A.2
Edmonson, J.H.3
Ritch, P.S.4
Shiraki, M.5
-
22
-
-
0028335697
-
Phase II study with docetaxel (taxotere) in advanced soft tissue sarcomas of the adult
-
Van Hoesel QGCM, Verweij J, Catimel G, et al: Phase II study with docetaxel (taxotere) in advanced soft tissue sarcomas of the adult. Ann Oncol 1994;5:539-542.
-
(1994)
Ann Oncol
, vol.5
, pp. 539-542
-
-
Van Hoesel, Q.G.C.M.1
Verweij, J.2
Catimel, G.3
-
23
-
-
0344484308
-
Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma: A phase II trial
-
Blackstein ME, Eisenhauer EA, Bramwell V, Belanger K, Verma S, Beare S: Docetaxel (taxotere) as first line therapy for metastatic or recurrent soft tissue sarcoma: A phase II trial. Eur J Cancer 1995;31A(suppl 5):177.
-
(1995)
Eur J Cancer
, vol.31 A
, Issue.5 SUPPL.
, pp. 177
-
-
Blackstein, M.E.1
Eisenhauer, E.A.2
Bramwell, V.3
Belanger, K.4
Verma, S.5
Beare, S.6
-
24
-
-
0343825696
-
Taxol in the treatment of recurrent or metastatic soft tissue or osteosarcomas
-
Gian V, Lynch J, McCarley D, Johnson T: Taxol in the treatment of recurrent or metastatic soft tissue or osteosarcomas. Proc Am Soc Clin Oncol 1995;14:516.
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 516
-
-
Gian, V.1
Lynch, J.2
McCarley, D.3
Johnson, T.4
-
25
-
-
0025896516
-
High dose DTIC in advanced soft tissue sarcomas of the adult. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
-
Buesa JM, Mouridsen HT, van Oosterom AT, et al: High dose DTIC in advanced soft tissue sarcomas of the adult. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Ann Oncol 1991;2:307-309.
-
(1991)
Ann Oncol
, vol.2
, pp. 307-309
-
-
Buesa, J.M.1
Mouridsen, H.T.2
Van Oosterom, A.T.3
-
26
-
-
0020459117
-
A one day combination chemotherapy (CyVADIC) regimen in soft tissue sarcomas
-
Bernard SA, Capizzi RL, Rudnick SA, Tremont SJ, Raymond RN: A one day combination chemotherapy (CyVADIC) regimen in soft tissue sarcomas. Proc Am Soc Clin Oncol 1982; 1:170.
-
(1982)
Proc Am Soc Clin Oncol
, vol.1
, pp. 170
-
-
Bernard, S.A.1
Capizzi, R.L.2
Rudnick, S.A.3
Tremont, S.J.4
Raymond, R.N.5
-
27
-
-
0018598519
-
Cisdichlorodiamineplatinum (II) in metastatic soft tissue sarcomas
-
Karakousis CP, Holterman OA, Holyoke E: Cisdichlorodiamineplatinum (II) in metastatic soft tissue sarcomas. Cancer Treat Rep 1979; 63:2071-2075.
-
(1979)
Cancer Treat Rep
, vol.63
, pp. 2071-2075
-
-
Karakousis, C.P.1
Holterman, O.A.2
Holyoke, E.3
-
28
-
-
0025183730
-
Phase II trial of carboplatin in soft tissue sarcoma
-
Goldstein D, Cheuvert B, Trump DL, et al: Phase II trial of carboplatin in soft tissue sarcoma. Am J Clin Oncol 1990;13:420-423.
-
(1990)
Am J Clin Oncol
, vol.13
, pp. 420-423
-
-
Goldstein, D.1
Cheuvert, B.2
Trump, D.L.3
-
29
-
-
0342918035
-
Phase II trials of topotecan in patients with malignant gliomas and soft tissue sarcoma
-
Eisenhauer AE, Wainman N, Boos G, MacDonald D, Bramwell V: Phase II trials of topotecan in patients with malignant gliomas and soft tissue sarcoma. Proc Am Soc Clin Oncol 1995;14:175.
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 175
-
-
Eisenhauer, A.E.1
Wainman, N.2
Boos, G.3
MacDonald, D.4
Bramwell, V.5
-
30
-
-
0345214053
-
Phase II trial of VP-16213 in adults with soft tissue sarcomas
-
Welt S, Magill GB, Sordillo PP, et al: Phase II trial of VP-16213 in adults with soft tissue sarcomas. Proc Am Soc Clin Oncol 1983;2:234.
-
(1983)
Proc Am Soc Clin Oncol
, vol.2
, pp. 234
-
-
Welt, S.1
Magill, G.B.2
Sordillo, P.P.3
-
31
-
-
0018913876
-
Clinical trial of VP-16213 (NSC 141540) iv twice weekly in advanced neoplastic disease
-
Nissen NI, Pajak TF, Leone LA, et al: Clinical trial of VP-16213 (NSC 141540) iv twice weekly in advanced neoplastic disease. Cancer 1980; 45:232-235.
-
(1980)
Cancer
, vol.45
, pp. 232-235
-
-
Nissen, N.I.1
Pajak, T.F.2
Leone, L.A.3
-
32
-
-
0015863032
-
Epidophyllotoxin VP16213 in treatment of leukemias, haematosarcomas and solid tumours
-
EORTC Clinical Screening Group: Epidophyllotoxin VP16213 in treatment of leukemias, haematosarcomas and solid tumours. Br Med J 1973;iii:199-202.
-
(1973)
Br Med J
, vol.3
, pp. 199-202
-
-
-
33
-
-
0016039711
-
Combination chemotherapy for metastatic sarcoma
-
Gottlieb JA: Combination chemotherapy for metastatic sarcoma. Cancer Chemother Rep 1974;58:265-270.
-
(1974)
Cancer Chemother Rep
, vol.58
, pp. 265-270
-
-
Gottlieb, J.A.1
-
34
-
-
0015436696
-
Chemotherapy of sarcomas with a combination of Adriamycin and dimethyl triazeno imidazole carboxamide
-
Gottlieb JA, Baker LH, Quagliani JM, et al: Chemotherapy of sarcomas with a combination of Adriamycin and dimethyl triazeno imidazole carboxamide. Cancer 1972;30:1632-1638.
-
(1972)
Cancer
, vol.30
, pp. 1632-1638
-
-
Gottlieb, J.A.1
Baker, L.H.2
Quagliani, J.M.3
-
35
-
-
0017159792
-
Role of DTIC (NSC 45388) in the chemotherapy of sarcomas
-
Gottlieb JA, Benjamin RS, Baker LH, et al: Role of DTIC (NSC 45388) in the chemotherapy of sarcomas. Cancer Treat Rep 1976;60: 199-203.
-
(1976)
Cancer Treat Rep
, vol.60
, pp. 199-203
-
-
Gottlieb, J.A.1
Benjamin, R.S.2
Baker, L.H.3
-
36
-
-
0015269578
-
Combination phase I-II study of imidazole carboxamide (NSC-45388)
-
Wagner DE, Ramirez G, Weiss AJ: Combination phase I-II study of imidazole carboxamide (NSC-45388). Oncology 1972;26:310-316.
-
(1972)
Oncology
, vol.26
, pp. 310-316
-
-
Wagner, D.E.1
Ramirez, G.2
Weiss, A.J.3
-
37
-
-
0017054734
-
A comparative clinical trial evaluating the combination of Adriamycin, DTIC and vincristine, the combination of actinomycin D. cyclophosphamide and vincristine, and a single agent methyl CCNU in advanced sarcoma
-
Creagan ET, Hahn RG, Ahmann DL, Edmonson J, Bisel HF, Eagan RT: A comparative clinical trial evaluating the combination of Adriamycin, DTIC and vincristine, the combination of actinomycin D. cyclophosphamide and vincristine, and a single agent methyl CCNU in advanced sarcoma. Cancer Treat Rep 1976;60: 1385-1387.
-
(1976)
Cancer Treat Rep
, vol.60
, pp. 1385-1387
-
-
Creagan, E.T.1
Hahn, R.G.2
Ahmann, D.L.3
Edmonson, J.4
Bisel, H.F.5
Eagan, R.T.6
-
38
-
-
0018880740
-
Cyclophosphamide, vincristine, Adriamycin and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas
-
Yap B, Baker LH, Sinkovics JG, et al: Cyclophosphamide, vincristine, Adriamycin and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 1980;64:93-98.
-
(1980)
Cancer Treat Rep
, vol.64
, pp. 93-98
-
-
Yap, B.1
Baker, L.H.2
Sinkovics, J.G.3
-
39
-
-
0018379243
-
Survival and relapse patterns of complete responders in adults with advanced soft tissue sarcomas
-
Yap BS, Sinkovics JG, Benjamin RS, et al: Survival and relapse patterns of complete responders in adults with advanced soft tissue sarcomas. Proc Am Assoc Cancer Res 1979;20:352.
-
(1979)
Proc Am Assoc Cancer Res
, vol.20
, pp. 352
-
-
Yap, B.S.1
Sinkovics, J.G.2
Benjamin, R.S.3
-
40
-
-
0029005580
-
Doxorubicin versus CyVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomised study of the EORTC Soft Tissue and Bone Sarcoma Group
-
Santoro A, Tursz T, Mouridsen H, et al: Doxorubicin versus CyVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomised study of the EORTC Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995;13:1537-1545.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1537-1545
-
-
Santoro, A.1
Tursz, T.2
Mouridsen, H.3
-
41
-
-
0344783296
-
Infusion chemotherapy for soft tissue sarcomas
-
Baker LH (ed): The Hague, Nijhoff
-
Benjamin RS, Yap BS: Infusion chemotherapy for soft tissue sarcomas; in Baker LH (ed): Soft Tissue Sarcomas. The Hague, Nijhoff, 1987.
-
(1987)
Soft Tissue Sarcomas
-
-
Benjamin, R.S.1
Yap, B.S.2
-
42
-
-
0023793647
-
A phase I-II study of ifosfamide in combination with Adriamycin in the treatment of adult soft tissue sarcoma
-
Mansi JL, Fisher C, Wiltshaw E, Macmillan S, King M, Stuart-Harris R: A phase I-II study of ifosfamide in combination with Adriamycin in the treatment of adult soft tissue sarcoma. Eur J Cancer Clin Oncol 1988;24:1439-1443.
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 1439-1443
-
-
Mansi, J.L.1
Fisher, C.2
Wiltshaw, E.3
Macmillan, S.4
King, M.5
Stuart-Harris, R.6
-
43
-
-
0025120497
-
Adriamycin plus ifosfamide in previously untreated patients with advanced soft tissue sarcomas
-
Schutte J, Mouridsen HT, Steward WP, et al: Adriamycin plus ifosfamide in previously untreated patients with advanced soft tissue sarcomas. Eur J Cancer 1990;26:558.
-
(1990)
Eur J Cancer
, vol.26
, pp. 558
-
-
Schutte, J.1
Mouridsen, H.T.2
Steward, W.P.3
-
44
-
-
0022469151
-
Doxorubicin, ifosfamide and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: A phase I study
-
Elias A, Antman KH: Doxorubicin, ifosfamide and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: A phase I study. Cancer Treat Rep 1986,70:827-833.
-
(1986)
Cancer Treat Rep
, vol.70
, pp. 827-833
-
-
Elias, A.1
Antman, K.H.2
-
45
-
-
0024452968
-
Response to mesna, doxorubicin, ifosfamide and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy
-
Elias A, Ryan L, Sulkes A, et al: Response to mesna, doxorubicin, ifosfamide and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol 1989;7:1208-1216.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1208-1216
-
-
Elias, A.1
Ryan, L.2
Sulkes, A.3
-
46
-
-
0023176119
-
Randomised comparison of Adriamycin regimens for treatment of metastatic soft tissue sarcomas
-
Borden EC, Amato D, Enterline HT, et al: Randomised comparison of Adriamycin regimens for treatment of metastatic soft tissue sarcomas. J Clin Oncol 1987;5:840-850.
-
(1987)
J Clin Oncol
, vol.5
, pp. 840-850
-
-
Borden, E.C.1
Amato, D.2
Enterline, H.T.3
-
47
-
-
0017156183
-
CYVADIC versus CYVADACT - A randomised trial of cyclophosphamide, vincristine and Adriamycin plus either dacarbazine or actinomycin D for advanced soft tissue sarcomas
-
Benjamin RS, Gottlieb JA, Baker LH: CYVADIC versus CYVADACT - a randomised trial of cyclophosphamide, vincristine and Adriamycin plus either dacarbazine or actinomycin D for advanced soft tissue sarcomas. Proc Am Assoc Cancer Res 1976;17:256.
-
(1976)
Proc Am Assoc Cancer Res
, vol.17
, pp. 256
-
-
Benjamin, R.S.1
Gottlieb, J.A.2
Baker, L.H.3
-
48
-
-
0023235065
-
Combination chemotherapy using Adriamycin, DTIC, cyclophosphamide and actinomycin D for advanced soft tissue sarcomas. A randomised comparative trial
-
Baker LH, Frank J, Fine G, et al: Combination chemotherapy using Adriamycin, DTIC, cyclophosphamide and actinomycin D for advanced soft tissue sarcomas. A randomised comparative trial. J Clin Oncol 1987;5:851-861.
-
(1987)
J Clin Oncol
, vol.5
, pp. 851-861
-
-
Baker, L.H.1
Frank, J.2
Fine, G.3
-
49
-
-
0025770430
-
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft tissue sarcomas. A Southwest Oncology Group Study
-
Zalupski M, Metch B, Balcerzak S, et al: Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft tissue sarcomas. A Southwest Oncology Group Study. J Natl Cancer Inst 1991;83:926-932.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 926-932
-
-
Zalupski, M.1
Metch, B.2
Balcerzak, S.3
-
50
-
-
0027280571
-
An Intergroup phase III randomised study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas
-
Antman K, Crowley J, Balcerzak SP, et al: An Intergroup phase III randomised study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-1285.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1276-1285
-
-
Antman, K.1
Crowley, J.2
Balcerzak, S.P.3
-
51
-
-
0027465117
-
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose intensity of chemotherapy in metastatic adult soft tissue sarcomas: A study of the EORTC Soft Tissue and Bone Sarcoma Group
-
Steward WP, Verweij J, Somers R, et al: Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose intensity of chemotherapy in metastatic adult soft tissue sarcomas: A study of the EORTC Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1993;11: 15-21.
-
(1993)
J Clin Oncol
, vol.11
, pp. 15-21
-
-
Steward, W.P.1
Verweij, J.2
Somers, R.3
-
52
-
-
0344351377
-
Is highdose chemotherapy of interest in advanced soft tissue sarcomas (ASTS)? An EORTC randomized phase III trial
-
Tursz T, Verweij J, Crowther D, et al: Is highdose chemotherapy of interest in advanced soft tissue sarcomas (ASTS)? An EORTC randomized phase III trial. Proc Am Soc Clin Oncol 1996;15:973.
-
(1996)
Proc Am Soc Clin Oncol
, vol.15
, pp. 973
-
-
Tursz, T.1
Verweij, J.2
Crowther, D.3
-
53
-
-
0028014423
-
Cytotoxic drugs plus subcutanous granulocyte macrophage colony-stimulating factor: Can molgramostim enhance antisarcoma therapy?
-
Edmonson JH, Long HJ, Kvols LK: Cytotoxic drugs plus subcutanous granulocyte macrophage colony-stimulating factor: Can molgramostim enhance antisarcoma therapy? J Natl Cancer Inst 1994;86:312-314.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 312-314
-
-
Edmonson, J.H.1
Long, H.J.2
Kvols, L.K.3
-
54
-
-
0345645899
-
The treatment of advanced soft tissue sarcoma with high dose doxorubicin plus granulocyte-macrophage colony-stimulating factor
-
in press
-
Hoekman K, Wagstaff J, van Groenwegen CJ, Vermorken JB, Meyer S, Pinedo HM: The treatment of advanced soft tissue sarcoma with high dose doxorubicin plus granulocyte-macrophage colony-stimulating factor. Ann Oncol, in press.
-
Ann Oncol
-
-
Hoekman, K.1
Wagstaff, J.2
Van Groenwegen, C.J.3
Vermorken, J.B.4
Meyer, S.5
Pinedo, H.M.6
-
55
-
-
0029001008
-
High dose ifosfamide: Circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas
-
Le Cesne A, Antoine E, Spielmann M, et al: High dose ifosfamide: Circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol 1995;13: 1600-1608.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1600-1608
-
-
Le Cesne, A.1
Antoine, E.2
Spielmann, M.3
-
56
-
-
0000674649
-
Phase II trials of ifosfamide and mesna in advanced soft tissue sarcoma patients
-
Cerny T, Leyvraz S, Daggi H, Varini M, Kroner T, Marti C: Phase II trials of ifosfamide and mesna in advanced soft tissue sarcoma patients. Proc Am Soc Clin Oncol 1992;11:416.
-
(1992)
Proc Am Soc Clin Oncol
, vol.11
, pp. 416
-
-
Cerny, T.1
Leyvraz, S.2
Daggi, H.3
Varini, M.4
Kroner, T.5
Marti, C.6
-
57
-
-
0009700589
-
High intensity scheduling of ifosfamide in adult patients with soft tissue sarcomas
-
Christman KL, Crapes ES, Schwartz EK: High intensity scheduling of ifosfamide in adult patients with soft tissue sarcomas. Proc Am Soc Clin Oncol 1993;12:470.
-
(1993)
Proc Am Soc Clin Oncol
, vol.12
, pp. 470
-
-
Christman, K.L.1
Crapes, E.S.2
Schwartz, E.K.3
-
58
-
-
0026480241
-
High dose chemotherapy with ABMT in soft tissue sarcomas: A report of 22 cases
-
Dumontet C, Biron P, Bouffet E, et al: High dose chemotherapy with ABMT in soft tissue sarcomas: A report of 22 cases. Bone Marrow Transplant 1992;10:405-408.
-
(1992)
Bone Marrow Transplant
, vol.10
, pp. 405-408
-
-
Dumontet, C.1
Biron, P.2
Bouffet, E.3
-
59
-
-
0008330816
-
High dose chemotherapy (VIC) and bone marrow support in advanced sarcomas
-
Blay JY, Bouhour D, Brunat-Mentigny M, et al: High dose chemotherapy (VIC) and bone marrow support in advanced sarcomas. Proc Am Soc Clin Oncol 1994;13:479.
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 479
-
-
Blay, J.Y.1
Bouhour, D.2
Brunat-Mentigny, M.3
-
60
-
-
0001222837
-
High dose therapy with autologous hematopoietic stem cell rescue for patients with metastatic soft tissue sarcoma
-
Kessinger A, Petersen K, Bishop M, Schmit-Pokorny K: High dose therapy with autologous hematopoietic stem cell rescue for patients with metastatic soft tissue sarcoma. Proc Am Soc Clin Oncol 1994;13:480.
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 480
-
-
Kessinger, A.1
Petersen, K.2
Bishop, M.3
Schmit-Pokorny, K.4
-
61
-
-
0343052877
-
Randomised study of high-dose epirubicin versus highdose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma
-
Jelic S, Kovcin V, Milanovic N, et al : Randomised study of high-dose epirubicin versus highdose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma. Eur J Cancer 1997; 33:220-225.
-
(1997)
Eur J Cancer
, vol.33
, pp. 220-225
-
-
Jelic, S.1
Kovcin, V.2
Milanovic, N.3
-
62
-
-
0344351376
-
Phase II trial of recombinant interferon-alpha-2b in the treatment of advanced metastatic and refractory sarcomas
-
Salem PA, Benjamin RS, Howard J, Gutterman JU: Phase II trial of recombinant interferon-alpha-2b in the treatment of advanced metastatic and refractory sarcomas. Proc Am Assoc Cancer Res 1991;32:200.
-
(1991)
Proc Am Assoc Cancer Res
, vol.32
, pp. 200
-
-
Salem, P.A.1
Benjamin, R.S.2
Howard, J.3
Gutterman, J.U.4
-
65
-
-
0023115642
-
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and IL-2 or high dose IL-2 alone
-
Rosenberg SA, Lotze MT, Muul LM, et al: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and IL-2 or high dose IL-2 alone. N Engl J Med 1987;316:889-897.
-
(1987)
N Engl J Med
, vol.316
, pp. 889-897
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Muul, L.M.3
-
66
-
-
0026647679
-
An out-patient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies
-
Rosso R, Sertoli MR, Queirolo P, et al: An out-patient phase I study of a subcutaneous interleukin-2 and intramuscular alpha-2a-interferon combination in advanced malignancies. Ann Oncol 1992;3:559-563.
-
(1992)
Ann Oncol
, vol.3
, pp. 559-563
-
-
Rosso, R.1
Sertoli, M.R.2
Queirolo, P.3
-
67
-
-
0028338750
-
Phase II study of liposomal muramyl tripeptide phosphatidylethonolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group Study
-
Verweij J, Judson I, Steward W, et al: Phase II study of liposomal muramyl tripeptide phosphatidylethonolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group Study. Eur J Cancer 1994;30:842-843.
-
(1994)
Eur J Cancer
, vol.30
, pp. 842-843
-
-
Verweij, J.1
Judson, I.2
Steward, W.3
-
68
-
-
85031413229
-
Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation. Results of a phase I study
-
Di Filippo F, Lise M, Rossi CR, et al: Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation. Results of a phase I study. Proc Am Soc Clin Oncol 1997;16:1800.
-
(1997)
Proc Am Soc Clin Oncol
, vol.16
, pp. 1800
-
-
Di Filippo, F.1
Lise, M.2
Rossi, C.R.3
-
69
-
-
0345214038
-
Hyperthermic isolated limb perfusion (HILP) with TNF-α and melphalan as a palliative treatment in patients with regional and/or distant metastases of locally advanced primarily irresectable soft tissue sarcomas (STS) of the extremity, stage IVA or IVB - Is it worthwhile?
-
Hoekstra HJ, Oliemann AFT, van Ginkel RJ, et al: Hyperthermic isolated limb perfusion (HILP) with TNF-α and melphalan as a palliative treatment in patients with regional and/or distant metastases of locally advanced primarily irresectable soft tissue sarcomas (STS) of the extremity, stage IVA or IVB - Is it worthwhile? Proc Am Soc Clin Oncol 1997;16:1801.
-
(1997)
Proc Am Soc Clin Oncol
, vol.16
, pp. 1801
-
-
Hoekstra, H.J.1
Oliemann, A.F.T.2
Van Ginkel, R.J.3
-
70
-
-
0024343159
-
Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcomas: A randomized trial of the Scandinavian Sarcoma Group
-
Alvegard TA, Sigurdsson H, Mouridsen H, Solheim O, Unsgaard B, Ringborg U, Dahl O, Nordentoft AM, Blomqvist C, Rydholm A, Stener B, Ranstam J: Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcomas: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989;7:1504-1513.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1504-1513
-
-
Alvegard, T.A.1
Sigurdsson, H.2
Mouridsen, H.3
Solheim, O.4
Unsgaard, B.5
Ringborg, U.6
Dahl, O.7
Nordentoft, A.M.8
Blomqvist, C.9
Rydholm, A.10
Stener, B.11
Ranstam, J.12
-
71
-
-
0022296896
-
Adjuvant doxorubicin for sarcoma: Data from the ECOG and DFCI/ MGH studies
-
Antman K, Amato D, Lemer H, Suit HD, Carson J, Wood WC, Proppe K, Carey R, Greenberger J, Wilson R: Adjuvant doxorubicin for sarcoma: Data from the ECOG and DFCI/ MGH studies. Cancer Treat Symp 1985;3: 109-115.
-
(1985)
Cancer Treat Symp
, vol.3
, pp. 109-115
-
-
Antman, K.1
Amato, D.2
Lemer, H.3
Suit, H.D.4
Carson, J.5
Wood, W.C.6
Proppe, K.7
Carey, R.8
Greenberger, J.9
Wilson, R.10
-
72
-
-
0001647048
-
Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10-year results and review of literature
-
Salmon SE (ed): Philadelphia, Saunders
-
Antman K, Ryan L, Borden E, Wood WC, Lerner HL, Corson JM, Carey R, Suit H, Balcerak S, Elias A, Baker L: Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10-year results and review of literature; in Salmon SE (ed): Adjuvant Therapy of Cancer. VI. Philadelphia, Saunders, 1990, pp 529-543.
-
(1990)
Adjuvant Therapy of Cancer
, vol.6
, pp. 529-543
-
-
Antman, K.1
Ryan, L.2
Borden, E.3
Wood, W.C.4
Lerner, H.L.5
Corson, J.M.6
Carey, R.7
Suit, H.8
Balcerak, S.9
Elias, A.10
Baker, L.11
-
73
-
-
84944374895
-
Doxorubicin chemotherapy in the treatment of soft tissue sarcoma: Combined results of two randomized trials
-
Wilson RE, Wood WC, Lerner HL, Antman K, Amato D, Corson JM, Proppe K, Harmon D, Carey R, Greenberger J, Suit H: Doxorubicin chemotherapy in the treatment of soft tissue sarcoma: Combined results of two randomized trials. Arch Surg 1986;121:1354-1359.
-
(1986)
Arch Surg
, vol.121
, pp. 1354-1359
-
-
Wilson, R.E.1
Wood, W.C.2
Lerner, H.L.3
Antman, K.4
Amato, D.5
Corson, J.M.6
Proppe, K.7
Harmon, D.8
Carey, R.9
Greenberger, J.10
Suit, H.11
-
74
-
-
0021681937
-
A randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas
-
Edmonson JH, Fleming TR, Ivans JC, Burgert O, Soule EH, O'Connell MJ, Sim FH, Ahmann DL: A randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol 1984;2:1390-1396.
-
(1984)
J Clin Oncol
, vol.2
, pp. 1390-1396
-
-
Edmonson, J.H.1
Fleming, T.R.2
Ivans, J.C.3
Burgert, O.4
Soule, E.H.5
O'Connell, M.J.6
Sim, F.H.7
Ahmann, D.L.8
-
75
-
-
0000387415
-
Adjuvant chemotherapy with CyVADIC in high risk soft tissue sarcoma: A randomized prospective trial
-
Salmon SE (ed): Philadelphia, Saunders
-
Ravaud A, Bui NB, Coindre JM, Kantor G, Stockle E, Lagarde P, Becouarn Y, Chauvergne J, Bonicon F, Maree D: Adjuvant chemotherapy with CyVADIC in high risk soft tissue sarcoma: A randomized prospective trial; in Salmon SE (ed): Adjuvant Therapy of Cancer. VI. Philadelphia, Saunders, 1990, pp 556-566.
-
(1990)
Adjuvant Therapy of Cancer. VI
, pp. 556-566
-
-
Ravaud, A.1
Bui, N.B.2
Coindre, J.M.3
Kantor, G.4
Stockle, E.5
Lagarde, P.6
Becouarn, Y.7
Chauvergne, J.8
Bonicon, F.9
Maree, D.10
-
76
-
-
0028334634
-
Adjuvant CyVADIC chemotherapy for adult soft tissue sarcoma -Reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
-
Bramwell V, Rouésse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, Rinka W, Priario J, Wagener TH, Burgers M, van Unnik J, Contesso G, Thomas D, Van Glabbeke M, Markham D, Pinedo H: Adjuvant CyVADIC chemotherapy for adult soft tissue sarcoma -Reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1994;12:1137-1149.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1137-1149
-
-
Bramwell, V.1
Rouésse, J.2
Steward, W.3
Santoro, A.4
Schraffordt-Koops, H.5
Buesa, J.6
Rinka, W.7
Priario, J.8
Wagener, T.H.9
Burgers, M.10
Van Unnik, J.11
Contesso, G.12
Thomas, D.13
Van Glabbeke, M.14
Markham, D.15
Pinedo, H.16
-
77
-
-
0022620002
-
A randomized trial for the treatment of high grade soft tissue sarcomas of the extremities: Preliminary observations
-
Gherlinzoni F, Bacci G, Picci P, Capanna R, Calderoni P, Lorenzi EG, Bernini M, Emiliani E, Barbieri E, Normand A, Campanacci M: A randomized trial for the treatment of high grade soft tissue sarcomas of the extremities: Preliminary observations. J Clin Oncol 1986;4: 552-558.
-
(1986)
J Clin Oncol
, vol.4
, pp. 552-558
-
-
Gherlinzoni, F.1
Bacci, G.2
Picci, P.3
Capanna, R.4
Calderoni, P.5
Lorenzi, E.G.6
Bernini, M.7
Emiliani, E.8
Barbieri, E.9
Normand, A.10
Campanacci, M.11
-
78
-
-
0023915852
-
A randomized prospective trial using postoperative chemotherapy (Adriamycin) in high grade extremity soft-tissue sarcoma
-
Eilber FR, Giuliano AE, Huth JF, Morton DL: A randomized prospective trial using postoperative chemotherapy (Adriamycin) in high grade extremity soft-tissue sarcoma. Am J Clin Oncol 1988;11:39-45.
-
(1988)
Am J Clin Oncol
, vol.11
, pp. 39-45
-
-
Eilber, F.R.1
Giuliano, A.E.2
Huth, J.F.3
Morton, D.L.4
-
79
-
-
0024215898
-
Adjuvant chemotherapy for patients with high grade soft tissue sarcomas of the extremity
-
Chang AE, Kinsella T, Glastein E, Baker AR, Sindelar WF, Lotze MT, Danforth DN, Sugarbaker PH, Lack EE, Steinberg SM, White DE, Rosenberg SA: Adjuvant chemotherapy for patients with high grade soft tissue sarcomas of the extremity. J Clin Oncol 1988;6:1491-1500.
-
(1988)
J Clin Oncol
, vol.6
, pp. 1491-1500
-
-
Chang, A.E.1
Kinsella, T.2
Glastein, E.3
Baker, A.R.4
Sindelar, W.F.5
Lotze, M.T.6
Danforth, D.N.7
Sugarbaker, P.H.8
Lack, E.E.9
Steinberg, S.M.10
White, D.E.11
Rosenberg, S.A.12
-
80
-
-
0001287518
-
The importance of combination chemotherapy for adjuvant treatment of high risk patients with soft tissue sarcomas of the extremities
-
Salmon SE (ed): V. New York, Grune & Stratton
-
Benjamin RS, Terjanian TO, Genoglio CJ, Barkley HT, Evans HC, Murphy WK, Martin RG: The importance of combination chemotherapy for adjuvant treatment of high risk patients with soft tissue sarcomas of the extremities; in Salmon SE (ed): Adjuvant Therapy. V. New York, Grune & Stratton, 1987, pp 735-744.
-
(1987)
Adjuvant Therapy
, pp. 735-744
-
-
Benjamin, R.S.1
Terjanian, T.O.2
Genoglio, C.J.3
Barkley, H.T.4
Evans, H.C.5
Murphy, W.K.6
Martin, R.G.7
-
81
-
-
0009351577
-
Adjuvant therapy for soft tissue sarcomas
-
Ryan JR, Baker LO (eds): Dordrecht, Kluwer Academic Publishers
-
Baker LH: Adjuvant therapy for soft tissue sarcomas; in Ryan JR, Baker LO (eds): Recent Concepts in Sarcoma Treatment. Dordrecht, Kluwer Academic Publishers, 1988, pp 131-136.
-
(1988)
Recent Concepts in Sarcoma Treatment
, pp. 131-136
-
-
Baker, L.H.1
-
82
-
-
0021914092
-
A randomized, perspective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast and trunk
-
Glenn J, Kinsella T, Galstein E, Tepper J. Baker A, Sugarbaker P, Sidelar W, Roth J, Brennan M, Costa J, Seipp C, Wesley R, Young RC, Rosenberg SA: A randomized, perspective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast and trunk. Cancer 1985;55:1206-1214.
-
(1985)
Cancer
, vol.55
, pp. 1206-1214
-
-
Glenn, J.1
Kinsella, T.2
Galstein, E.3
Tepper, J.4
Baker, A.5
Sugarbaker, P.6
Sidelar, W.7
Roth, J.8
Brennan, M.9
Costa, J.10
Seipp, C.11
Wesley, R.12
Young, R.C.13
Rosenberg, S.A.14
-
83
-
-
0022006615
-
A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: A Gynaecologic Oncology Group Study
-
Omura GA, Blessing JA, Major F, Lifshitz S, Ehrlich CE, Mangan C, Beecham J, Patak R, Silverberge S: A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: A Gynaecologic Oncology Group Study. J Clin Oncol 1985;3:1240-1245.
-
(1985)
J Clin Oncol
, vol.3
, pp. 1240-1245
-
-
Omura, G.A.1
Blessing, J.A.2
Major, F.3
Lifshitz, S.4
Ehrlich, C.E.5
Mangan, C.6
Beecham, J.7
Patak, R.8
Silverberge, S.9
-
84
-
-
0031566814
-
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data
-
Sarcoma Meta-Analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Lancet 1997;350:1647-1654.
-
(1997)
Lancet
, vol.350
, pp. 1647-1654
-
-
|